HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Results of systemic pemetrexed-based combination chemotherapy versus cytoreductive surgery and hyperthermic intraperitoneal cisplatin and doxorubicin on survival in malignant peritoneal mesothelioma.

AuthorsAkshat Saxena, Terence C Chua
JournalLung cancer (Amsterdam, Netherlands) (Lung Cancer) Vol. 66 Issue 2 Pg. 269-70 (Nov 2009) ISSN: 1872-8332 [Electronic] Ireland
PMID19733416 (Publication Type: Comment, Comparative Study, Letter)
Chemical References
  • Glutamates
  • Pemetrexed
  • Guanine
  • Doxorubicin
  • Cisplatin
Topics
  • Antineoplastic Combined Chemotherapy Protocols (therapeutic use)
  • Cisplatin (administration & dosage, therapeutic use)
  • Combined Modality Therapy
  • Doxorubicin (administration & dosage, therapeutic use)
  • Glutamates (therapeutic use)
  • Guanine (analogs & derivatives, therapeutic use)
  • Humans
  • Injections, Intraperitoneal
  • Mesothelioma (drug therapy, mortality, surgery)
  • Pemetrexed
  • Peritoneal Neoplasms (drug therapy, mortality, surgery)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: